Medicaid policies for HIV-related prescription drugs.
As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid drug policies will have a substantial impact. State Medicaid programs were surveyed to identify policies on a range of prescription drug policies affecting these recipients. All Medicaid programs provide prescription drug benefits to all categorically needy recipients, and about three-fourths of the States provide these benefits to medically needy recipients. However, utilization limits, copayments, and off-label-use and prior-authorization policies in many States weaken the drug benefit available.
University of Illinois, Champaign, IL 61820.
R J
RJ
Buchanan
S R
SR
Smith
D017047:Cost Sharing; D003625:Data Collection; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D004608:Eligibility Determination; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics*; D006291:Health Policy / Q000191:economics; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000706:statistics & numerical data; D008484:Medicaid / Q000191:economics* / Q000706:statistics & numerical data; D013221:State Health Plans / Q000191:economics; D014481:United States